Abstract
Objective: To evaluate [11C]verapamil kinetics in humans. Methods: After intravenous injection of [11C]verapamil (370 MBq, specific activity >1600 GBq/mmol), kinetics were evaluated in five cancer patients using positron emission tomography (PET). Results: One hour after injection, accumulation of [11C] in lungs, heart and tumour was 43.0%, 1.3% and 0.9% of the injected verapamil dose, respectively. Half-lives of [11C]verapamil in these tissues were 46.2 min, 73.8 min and 23.7 min, respectively. Conclusions: Intravenously administered [11C] was mainly extracted by the lungs. Transport of a [11C]verapamil bolus out of solid tumour tissue is relatively fast.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Accepted in revised form: 22 November 2000
Electronic Publication
Rights and permissions
About this article
Cite this article
Hendrikse, N., de Vries, E., Franssen, E. et al. In vivo measurement of [11C]verapamil kinetics in human tissues. Eur J Clin Pharmacol 56, 827–829 (2001). https://doi.org/10.1007/s002280000253
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002280000253